Health Condition 1: O- Medical and Surgical
Conditions
Interventions
Intervention1: Inj. Levobupivacaine 0.25%: Inj. Levobupivacaine (20ML) 0.25% through intraperitoneal route with hourly VAS monitoring upto 12 hours
Control Intervention1: Inj. Ropivacaine 0.25%: Inj.
Sponsors
Vaibhavi Singh
Eligibility
Inclusion criteria
Inclusion criteria: ASA1 AND ASA2 PATIENTS, PATIENT UNDERGOING LAPROSCOPIC SURGERIES UNDER GENERAL ANAESTHESIA, HEMODYNAMICALLY STABLE WITH ALL ROUTINE INVESTIGATION WITHIN NORMAL LIMIT, AVAILABILITY OF INFORMED CONSENT
Exclusion criteria
Exclusion criteria: Patient with ASA 3 or more, patients below 18 years and above 65 years, patient posted for emergency procedures, patient with major neurological, cardiac, respiratory, metabolic, renal, hepatic disease or with coagulation abnormality, patients with known allergies to study drug.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To Estimate the Efficacy of Ropivacaine And Levobupivacaine Intraperitoneal Block In Laparoscopic Surgeries as quality of analgesia provided by the drug by monitoring VAS score and vitals of the patient every hour for the next 12 hoursTimepoint: Post operatively visual assessment scoring will be done for pain, monitoring will be done 1 hourly for the next 12 hours. | — |
Secondary
| Measure | Time frame |
|---|---|
| To determine the duration of post operative analgesia, adverse effects of drugs if any, to evaluate the complication if anyTimepoint: Post operatively visual assessment scoring will be done for pain, monitoring will be done 1 hourly for the next 12 hours. | — |
Countries
India
Contacts
Public ContactDr. Anjali Sherawat
DR. D. Y. PATIL MEDICAL COLLEGE, HOSPITAL AND RESEARCH CENTRE, Pimpri, Pune
Outcome results
None listed